Osteoarthritis drug developer Paradigm says its purchase of an oral drug candidate won't distract it from its key phase III .

Kalshi, a prediction market platform, has raised a $185 million investment round, pushing its valuation to $2 billion.

Despite major advances, real-world data show diminishing survival outcomes and treatment-limiting toxicities in second line ...

Kalshi raises $185M at $2B valuation, signaling prediction market maturity and crypto sector growth amid regulatory challenges.

GTE raised $15M in Series A funding led by Paradigm, aiming to become the fastest decentralized exchange and rival major ...

Kalshi achieved unicorn status following its latest Series C funding round, amid the prediction markets platform's growing ...

Paradigm has filed an amicus brief arguing the jury in the case against Tornado Cash co-founder Roman Storm needs clarity on ...

Special rapporteur warns against exploitation of migrant workers, condemns Gaza war as assault on right to health - Anadolu ...